Aberrant expression of nuclear prothymosin α contributes to epithelial-mesenchymal transition in lung cancer.
Saved in:
| Title: | Aberrant expression of nuclear prothymosin α contributes to epithelial-mesenchymal transition in lung cancer. |
|---|---|
| Authors: | Chen L; Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO, USA., Wang CT; Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Tong Yuan Diabetes Center, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chang JM; Thoracic Division, Department of Surgery, Ditmanson Medical Foundation Chiayi Christian Hospital, Taiwan.; Institute of Molecular Biology, National Chung Cheng University, Chiayi, Taiwan., Shiau AL; Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Tong Yuan Diabetes Center, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Shieh GS; Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Urology, Tainan Hospital, Ministry of Health and Welfare, Taiwan., Tseng YL; Division of Thoracic Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Yen YT; Division of Thoracic Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Huang TH; Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Cheng LH; Core Laboratory of Organoids Technology, Office of R&D, Taipei Medical University, Taiwan., Wu YC; School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taiwan.; TMU Research Center of Thoracic Medicine, Taipei Medical University, Taiwan., Wu CL; Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Tong Yuan Diabetes Center, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Institute of Molecular Biology, National Chung Cheng University, Chiayi, Taiwan., Su BH; School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taiwan.; TMU Research Center of Thoracic Medicine, Taipei Medical University, Taiwan., Wu P; Keele Medical School, Keele University, UK. |
| Source: | Molecular oncology [Mol Oncol] 2025 Sep; Vol. 19 (9), pp. 2730-2749. Date of Electronic Publication: 2025 Apr 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1878-0261 |
|---|---|
| DOI: | 10.1002/1878-0261.70035 |
